Company intelligence
Frontier Clinical Trials Ltd
Trials That Reflect Everyone. Research That Works for All.
About Frontier Clinical Trials Ltd
At Frontier, we believe clinical trials should work for everyone. Thatโs why weโve built a new kind of partner for sponsors: a ๐๐ข๐ญ๐ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ ๐๐ซ๐ ๐๐ง๐ข๐ฌ๐๐ญ๐ข๐จ๐ง ๐ฐ๐ข๐ญ๐ก ๐๐๐-๐ฅ๐๐ฏ๐๐ฅ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ข๐ฌ๐. We combine hands-on site operations with comprehensive trial management, giving you speed, access and value under one roof. Our model is built on three pillars: ๐๐ฉ๐๐๐ - Faster site start-up, faster recruitment, earlier submissions. ๐๐๐๐๐ฌ๐ฌ - Direct access to sites, representative patients, and specialist expertise. ๐๐๐ฅ๐ฎ๐ - CRO-level outcomes without CRO-level overheads. With research sites across the UK and plans for international expansion, we provide the infrastructure, regulatory support, patient engagement, and expert management needed to keep studies on track, strengthen data quality, and protect investment. Our senior team brings ๐๐+ ๐ฒ๐๐๐ซ๐ฌ ๐จ๐ ๐๐๐, ๐ฉ๐ก๐๐ซ๐ฆ๐, ๐๐ง๐ ๐๐ข๐จ๐ญ๐๐๐ก ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐, ensuring timelines stay on schedule, delays are avoided, and budgets are safeguarded. ๐ ๐๐ก๐ฒ ๐ฌ๐ฉ๐จ๐ง๐ฌ๐จ๐ซ๐ฌ ๐๐ก๐จ๐จ๐ฌ๐ ๐ ๐ซ๐จ๐ง๐ญ๐ข๐๐ซ โข Faster time to first patient and earlier submissions โข Inclusive, representative recruitment that meets modern regulatory demands โข Cost-effective operations that maximise Return On Investment โข A single partner for site delivery and trial management ๐ ๐ซ๐จ๐ง๐ญ๐ข๐๐ซ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ซ๐ข๐๐ฅ๐ฌ: ๐๐ซ๐ข๐๐ฅ๐ฌ ๐ญ๐ก๐๐ญ ๐ซ๐๐๐ฅ๐๐๐ญ ๐๐ฏ๐๐ซ๐ฒ๐จ๐ง๐. ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ญ๐ก๐๐ญ ๐ฐ๐จ๐ซ๐ค๐ฌ ๐๐จ๐ซ ๐๐ฅ๐ฅ.
Verified activity
Signals from Frontier Clinical Trials Ltd
2 published signals
Research & Knowledge
Frontier Clinical Trials Ltd published a report from Global Genes involving patient communities early and keeping them involved throughout the process.
Reported by Frontier Clinical Trials Ltd
Products & Services
Frontier Clinical Trials Ltd is building a model for clinical research that connects sponsors with the right patients, the right data, and the right research sites across diverse populations and markets using its AI-driven patient identification technology.
Reported by Frontier Clinical Trials Ltd